Speaker

Jonel Trebicka, MD, PhD

Jonel Trebicka, MD, PhD

Biography

Since 2022 Full University Professor of Medicine and Chair of Gastroenterology andHepatology in University of MünsterSince 2024 Deputy Director of European Foundation for Chronic Liver failure, Barcelona,Spain2018-2022 University Professor for Translational Hepatology in Department of InternalMedicine I, Goethe University Clinic FrankfurtSince 2017 Principal Investigator of the PREDICT study and Professor in EuropeanFoundation for Chronic Liver failure, Barcelona, Spain2017-2020 Visiting Professor in Institute for Bioengineering of Catalonia2015-2025 Adjunct Professor for Gastroenterology and Hepatology in University ofSouthern Denmark, Odense, Denmark2014 PhD at the University of Kopenhagen, Denmark2012 "Venia legendi" in Internal Medicine (Priv.-Doz./Ass.-Prof.) University of Bonn2005 MD thesis (Dr. med.) at University of Bonn, Germany2004 Final medical examination, University of Bonn, Germany1998 - 2004 Medical School, University of Bonn, GermanyClinical path:2024 Board Exam for Internal Medicine and Infectious Diseases2022 Board Exam for Intesive Care2022 Board Exam for Infectious Diseases2021 Coordinator of Interdisciplinary Universitary Liver Center, Frankfurt2021 Head of Liver Transplant outpatient Clinic, Goethe University Clinic Frankfurt2018 Head of TIPS-Programm in Department of Internal Medicine I, Frankfurt2013-2018 Head of TIPS-outpatient Clinic, Department of Internal Medicine I, Bonn2013 Board Exam for Gastroenterology and Hepatology2012-2018 Consultant for Gastroenterology and Hepatology, Endoscopy and ICU,Department of Internal Medicine I, University Clinic Bonn2011 Board Exam for Internal Medicine2005-2011 Resident in Internal Medicine and Gastroenterology/Hepatology Departmentof Internal Medicine I, University Clinic BonnOngoing Funding (Funder); Role; Total volume:2019 - 2023 CRC 1382 (DFG): Functional Circuits and Therapeutic Targets; PI2019 – 2024 H2020 (EC): MICROBiome-based biomarkers to PREDICT decompensation ofliver cirrhosis and treatment response; Coordinator2019 – 2024 Eurostars (DLR/BMBF): DEFIBER; Partner2020 – 2025 H2020 (EC): DECISION; Workpackage-leader2021 – 2024 BMBF (LiSyM-Cancer): DEEP-HCC; Partner2022 – 2025 LOEWE: ACLF-Initiative; Coordinator